Pulmonx Corporation

    Jurisdiction
    United States
    LEI
    549300WZMFR0ZK7RJY40
    ISIN
    US7458481014 (LUNG)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    3 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. Read full profile

    Fundamentals

    Net revenue
    €77.23M
    Gross margin
    73.2%
    EBIT
    -€50.01M
    EBIT margin
    -64.7%
    Net income
    -€48.57M
    Net margin
    -62.9%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €97.68M +26.5% -€48.61M +0.1%
    €121.29M +24.2% -€36.41M -25.1%
    €167.28M +37.9% -€3.10M -91.5%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Joshi Mehul Chief Financial Officer & PAO -7.9K $1.60 -$12.70K
    Lehman David Aaron GENERAL COUNSEL -9.8K $1.60 -$15.63K
    Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER -6.5K $1.60 -$10.47K
    Williamson Steven S. PRESIDENT AND CEO -9.6K $1.60 -$15.44K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 165K $1.11M -55K Sell

    Earnings Calls

    Latest earnings call: May 1, 2024 (Q1 2024)

    Add to watchlist

    Notifications